Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor <scp>PTC</scp>‐209 in acute myeloid leukemia: Implications for leukemia therapy

Yuki Nishida(Saga University), Kensuke Kojima(Saga University)
Cancer Science
October 9, 2015
10.1111/cas.12833
Cited by 27

Related Papers

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
|Blood Cancer Journal|2017|105
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
|Oncotarget|2016|13